Justify residue acceptance limits
Carryover limits require toxicological justification and consideration of equipment trains.
CV-REQ-000002
EU GMP Annex 15: Qualification and Validation§ 10.6
TOPIC EXPLORER
Acceptance Criteria
Documented decisions about limits, measurement and acceptance.
6 connected references
Use visual inspection within validation
Visual inspection alone is generally insufficient for cleaning validation.
CV-REQ-000005
EU GMP Annex 15: Qualification and Validation§ 10.2
Describe the cleaning study
Protocols should describe equipment, procedures, criteria and sample collection.
CV-REQ-000015
Q7A: Good Manufacturing Practice for APIs§ 12.7 — protocol
Distinguish HBELs from cleaning alert limits
An HBEL is not automatically the operational cleaning limit.
CV-REQ-000022
HBEL and cross-contamination: questions and answers§ Q6
Assess cleaning-agent residues
Consider the selection and removal of cleaning agents.
CV-REQ-000028
Cleaning validation guide (GUI-0028)§ 12.1
Evaluate visual inspection capability
Reliance on visual inspection needs evidence supporting the intended limit.
CV-REQ-000030
Cross-contamination control and HBEL Q&As§ Inspectorate commentary — visual inspection
Practical guidance
The Cleaning Validation Data Shift: From Offline Results to Process Intelligence
At-line TOC, in-line UV and automated process capability monitoring are moving cleaning data from a laboratory result reported days later to a signal produced during the cycle. A close reading of what is proven, what standards actually require, and what remains a promising research proposal.
Visual Clean Is Important — but When Is It Enough?
Visual inspection was present in every one of the cleaning findings FDA issued between 2024 and 2026 — never as the accused technique, always as the whole of the evidence. The distinction between a qualified visual method and a visual-only release decision is the difference between a control and an assumption.
HPLC, LC-MS/MS, TOC, UV or Visual Inspection? Choosing a Cleaning Validation Method by Risk
The analytical method is not a laboratory preference — it is the part of the cleaning validation strategy that decides whether a limit is actually measurable. The useful question is not which technique is 'best' but which technique matches the residue, the acceptance limit, the sampling method and the surface. This analysis walks through the trade-offs using published recovery, detection and clearance data, and shows why a method chosen before the residue is characterised tends to fail at the limit rather than at the bench.
From Three Runs to Lifecycle Control: What Continued Cleaning Verification Really Means
The three-run cleaning validation was never a requirement — it was the convention that grew where guidance was silent. PI 006-4, the ASTM cleaning standards and three recent FDA warning letters all point at the same thing: what has to be maintained is a validated state, and continued cleaning verification is how you know it still holds.
A MACO Is Only as Good as the Assumptions Behind It
A maximum allowable carry-over value is a PDE multiplied by a set of process assumptions — batch size, dose, surface area, recovery and the cleaning step itself. Read as a body of evidence, the 2025–2026 enforcement record is rarely about toxicity assessment, and almost always about those assumptions.
PIC/S Publishes PI 006-4: A New Qualification and Validation Recommendation Takes Effect in October
PIC/S has published PI 006-4, the revised Recommendations on Qualification and Validation, superseding the 2007 PI 006-3 and entering into force on 1 October 2026. Cleaning validation now occupies a full chapter, with HBEL-driven scope, explicit limits on visual inspection and a clear position against continued test-until-clean practice.
FDA Challenges a Visual-Only Cleaning Validation Strategy
A 2026 FDA warning letter to Dabur India rejects a shared-equipment cleaning programme that relied exclusively on visual inspection. The objection is narrower than it appears — and it turns on missing quantitative limits, not on visual inspection itself.
Worst Case or Product-Specific? New Research Reopens the Cleaning Validation Strategy Debate
A comparative review in the PDA Journal weighs worst-case matrices against product-specific validation and proposes a hybrid model anchored on visible residue limits.
EU and PIC/S Start the Next Revision of Annex 15 — What Validation Teams Should Watch
A joint EMA–PIC/S concept paper proposes extending Annex 15 to active substance manufacturers and aligning it with ICH Q9(R1). The current Annex 15 stays in force, and the earliest a revised text could be published is 2028.
AI Enters Continued Cleaning Process Verification — but the Statistics Come First
A January 2026 AAPS PharmSciTech paper proposes normalising every residue result to a percentage of its own specification limit, so that cleaning data from different products can finally be pooled, analysed non-parametrically and monitored as a Stage 3 capability index. The statistical argument is the substance; the AI framing is thinner than the title suggests.
A Cleaning Validation Can Age: What Happens When Products Change but the Study Does Not
The FDA's August 2025 warning letter to ABBE Laboratories describes a 2009 cleaning validation still standing while a harder-to-clean product was introduced onto the same shared kettle — and no change-control step that caught it.
Can Cleaning Be Monitored in Real Time? In-Line UV Moves Validation Closer to PAT
A STERIS-authored article in Pharmaceutical Technology reports that in-line UV spectrometry at 220 nm can follow a biopharmaceutical cleaning cycle continuously, from heavily soiled rinse to baseline. The data are encouraging, the framing is vendor-supplied, and the distance between process monitoring and a release decision is where our own thinking has to do the work.
Should Cleaning Validation Extend Into the QC Laboratory?
A 2025 DARU Journal of Pharmaceutical Sciences study builds a structured cleaning-validation protocol for QC-lab glassware and stainless-steel equipment, using oxcarbazepine as worst-case API and pairing HPLC residue analysis with conductivity and TOC detergent checks.
ASTM E3470-25: Cleaning Risk Management Gets a Dedicated Method Standard
ASTM International has published E3470-25, a first-edition guide on using FMECA and HACCP/HARPC to identify, analyse and control risk in pharmaceutical and medical device cleaning processes. It is the method layer that E3106 required but did not fully specify.
ASTM Updates Its HBEL Guide: What E3219-25 Means for Cleaning Validation
ASTM has re-issued E3219 as E3219-25, the current reference for deriving health-based exposure limits. HBELs are a decade-old regulatory expectation, not a 2025 novelty — but the revision sharpens how limits are derived, documented and defended.
Do Cleaning Validation Programmes Need Every Analytical Test They Currently Run?
A lightning talk at PDA Week 2025 argued for a lean approach to analytical panels in cleaning validation. The independent framework to justify it already exists in ASTM E3106 and ICH Q9(R1) — but only if the arithmetic is documented.
INTERPHEX 2025: Process Monitoring Reaches the Cleaning Suite
INTERPHEX 2025 in New York put cleaning validation on the process-monitoring agenda: a dedicated panel on analytics, contamination control and sustainability, plus cleanroom and environmental-monitoring sessions. Industry-press report from Javits Center, 1-3 April 2025.
What Does 'Clean' Mean When Equipment Status and Physical Condition Disagree?
A March 2025 FDA warning letter to Aspen Biopharma Labs Private Limited records investigators finding manufacturing equipment labelled "Cleaned" while liquid with a floating substance or residue remained on product-contact surfaces. That gap between a status tag and physical reality is one of the most consequential — and most preventable — failures in cleaning validation.
Visual Inspection Alone Was Not Enough: What FDA Expected to See
In Warning Letter 320-25-38 the FDA did not attack visual inspection as a technique. It objected to a cleaning programme in which visual inspection was the only evidence on the table — no acceptance criteria for carryover residues, no analytical data, and no procedures for the rest of the equipment train.
Cleaning Validation Meets Waste Treatment: A Study of SGLT-2 Inhibitor Residues
A NIPER-Ahmedabad group pairs a validated RP-HPLC surface-residue method for three SGLT-2 inhibitors with a detoxification strategy for the resulting cleaning waste.
ASTM Puts Process Capability on the Cleaning Validation Agenda
ASTM work item WK92658 wants to standardise how cleaning processes are judged capable — one-sided limits, small data sets, non-normal residues and continued verification included. It is the statistical gap E3106 left open.
What Happens to Biologics During Cleaning? New Data on Cleaning-Induced Protein Degradants
A bench-scale study puts the 650 ug/dose parenteral PDE for cleaning-induced protein degradants to the test with human-cell immunogenicity assays on HLE BiTE and mAb degradants, spiked into the same and a cross product.
Cleaning Validation Beyond Manufacturing Vessels: What About Blister Packaging?
A German hospital-pharmacy study argues blister-machine cleaning is a mandatory duty of care, and shows UV-Vis spectroscopy can replace HPLC as the analytical method.